Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1992 Jun;106(2):342–347. doi: 10.1111/j.1476-5381.1992.tb14338.x

The effects of combined angiotensin converting enzyme inhibition and beta-adrenoceptor blockade on plasma renin activity in anaesthetized dogs.

D Cambridge 1, M V Whiting 1, L J Butterfield 1, G Allan 1
PMCID: PMC1907514  PMID: 1356560

Abstract

1. The effects of beta-adrenoceptor blockade on the changes in plasma renin activity (PRA) following angiotensin enzyme (ACE) inhibition were investigated in pentobarbitone-chloralose anaesthetized dogs. 2. ACE-inhibition, with enalapril (2 mg kg-1), caused a significant reduction in systemic arterial blood pressure (BP) with little or no effect on cardiac function, and a significant elevation of plasma renin activity (PRA). By contrast beta-adrenoceptor blockade with atenolol (1 mg kg-1), caused a similar reduction in BP but in addition, significantly reduced cardiac function and PRA. 3. A combination of enalapril with atenolol, caused a significant reduction in BP, cardiac function and PRA, hence there was no elevation of PRA, as was seen following ACE-inhibition with enalapril alone. 4. The observations with beta-adrenoceptor blockade alone, show that there is an important homeostatic role for the renal sympathetic innervation, mediated by beta-adrenoceptors, in controlling basal renin levels. Furthermore, the renal sympathetic innervation appears to be an important contributor to the renin release caused by an ACE-inhibitor as the additional presence of a beta-adrenoceptor blocking agent will prevent this release. 5. BW B385C (2 mg kg-1), which combines both ACE-inhibition and beta-adrenoceptor blocking properties, also produced reductions in BP and cardiac function similar to those seen with the enalapril/atenolol combination. In addition, for an equivalent degree of ACE-inhibition by BW 385C, to that seen with enalapril alone, the elevation of PRA was attenuated.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
342

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antonaccio M. J., Harris D., Goldenberg H., High J. P., Rubin B. The effects of captopril, propranolol, and indomethacin on blood pressure and plasma renin activity in spontaneously hypertensive and normotensive rats. Proc Soc Exp Biol Med. 1979 Dec;162(3):429–433. doi: 10.3181/00379727-162-40697. [DOI] [PubMed] [Google Scholar]
  2. Belz G. G., Essig J., Kleinbloesem C. H., Hoogkamer J. F., Wiegand U. W., Wellstein A. Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflex. Br J Clin Pharmacol. 1988 Nov;26(5):547–556. doi: 10.1111/j.1365-2125.1988.tb05294.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bing J., Poulsen K. Time course of changes in plasma renin after blockade of the renin-system. Studies of conscious and anaesthetized, normal, adrenalectomized and spontaneously hypertensive rats. Acta Pathol Microbiol Scand A. 1975 Sep;83(5):454–466. doi: 10.1111/j.1699-0463.1975.tb00156.x. [DOI] [PubMed] [Google Scholar]
  4. Birbari A. Intrarenal factors in the control of renin secretion. Pflugers Arch. 1972;337(1):29–37. doi: 10.1007/BF00587869. [DOI] [PubMed] [Google Scholar]
  5. Blair-West J. R., Coghlan J. P., Denton D. A., Funder J. W., Scoggins B. A., Wright R. D. Inhibition of renin secretion by systemic and intrarenal angiotensin infusion. Am J Physiol. 1971 May;220(5):1309–1315. doi: 10.1152/ajplegacy.1971.220.5.1309. [DOI] [PubMed] [Google Scholar]
  6. Cambridge D., Whiting M. V., Allan G. Cardiac and renovascular effects in the anaesthetized dog of BW A575C: a novel angiotensin converting enzyme inhibitor with beta-adrenoceptor blocking properties. Br J Pharmacol. 1988 Jan;93(1):165–175. doi: 10.1111/j.1476-5381.1988.tb11418.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Churchill P. C., Churchill M. C., McDonald F. D. Renin secretion and distal tubule Na+ in rats. Am J Physiol. 1978 Dec;235(6):F611–F616. doi: 10.1152/ajprenal.1978.235.6.F611. [DOI] [PubMed] [Google Scholar]
  8. Dorward P. K., Riedel W., Burke S. L., Gipps J., Korner P. I. The renal sympathetic baroreflex in the rabbit. Arterial and cardiac baroreceptor influences, resetting, and effect of anesthesia. Circ Res. 1985 Oct;57(4):618–633. doi: 10.1161/01.res.57.4.618. [DOI] [PubMed] [Google Scholar]
  9. Holmquist B., Bünning P., Riordan J. F. A continuous spectrophotometric assay for angiotensin converting enzyme. Anal Biochem. 1979 Jun;95(2):540–548. doi: 10.1016/0003-2697(79)90769-3. [DOI] [PubMed] [Google Scholar]
  10. Keeton T. K., Pettinger W. A., Campbell W. B. The effects of altered sodium balance and adrenergic blockade on renin release induced in rats by angiotensin antagonism. Circ Res. 1976 Jun;38(6):531–539. doi: 10.1161/01.res.38.6.531. [DOI] [PubMed] [Google Scholar]
  11. Korner P. I., Langsford G., Starr D., Uther J. B., Ward W., White S. W. The effects of chloralose-urethane and sodium pentobarbitone anaesthesia on the local and autonomic components of the circulatory response to arterial hypoxia. J Physiol. 1968 Dec;199(2):283–302. doi: 10.1113/jphysiol.1968.sp008654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. MacGregor G. A., Markandu N. D., Smith S. J., Sagnella G. A. Captopril: contrasting effects of adding hydrochlorothiazide, propranolol, or nifedipine. J Cardiovasc Pharmacol. 1985;7 (Suppl 1):S82–S87. [PubMed] [Google Scholar]
  13. Meggs L. G., Hollenberg N. K. Converting enzyme inhibition and the kidney. Hypertension. 1980 Jul-Aug;2(4):551–557. doi: 10.1161/01.hyp.2.4.551. [DOI] [PubMed] [Google Scholar]
  14. Naftilan A. J., Oparil S. Inhibition of renin release from rat kidney slices by the angiotensins. Am J Physiol. 1978 Jul;235(1):F62–F68. doi: 10.1152/ajprenal.1978.235.1.F62. [DOI] [PubMed] [Google Scholar]
  15. Osborn J. L., DiBona G. F., Thames M. D. Beta-1 receptor mediation of renin secretion elicited by low-frequency renal nerve stimulation. J Pharmacol Exp Ther. 1981 Feb;216(2):265–269. [PubMed] [Google Scholar]
  16. Pickering T. G., Case D. B., Sullivan P. A., Laragh J. H. Comparison of antihypertensive and hormonal effects of captopril and propranolol at rest and during exercise. Am J Cardiol. 1982 Apr 21;49(6):1566–1568. doi: 10.1016/0002-9149(82)90392-7. [DOI] [PubMed] [Google Scholar]
  17. Schiffrin E. L., Gutkowska J., Genest J. Mechanism of Captopril-induced renin release in conscious rats. Proc Soc Exp Biol Med. 1981 Jul;167(3):327–332. doi: 10.3181/00379727-167-41173. [DOI] [PubMed] [Google Scholar]
  18. Schiffrin E. L., Gutkowska J., Thibault G., Genest J. Effect of enalapril (MK-421), an orally active angiotensin I converting enzyme inhibitor, on blood pressure, active and inactive plasma renin, urinary prostaglandin E2, and kallikrein excretion in conscious rats. Can J Physiol Pharmacol. 1984 Jan;62(1):116–123. doi: 10.1139/y84-019. [DOI] [PubMed] [Google Scholar]
  19. Shade R. E., Davis J. O., Johnson J. A., Witty R. T. Effects of renal arterial infusion of sodium and potassium on renin secretion in the dog. Circ Res. 1972 Nov;31(5):719–727. doi: 10.1161/01.res.31.5.719. [DOI] [PubMed] [Google Scholar]
  20. Vander A. J., Geelhoed G. W. Inhibition of renin secretion by angiotensin. II. Proc Soc Exp Biol Med. 1965 Nov;120(2):399–403. doi: 10.3181/00379727-120-30547. [DOI] [PubMed] [Google Scholar]
  21. Zimpfer M., Manders W. T., Barger A. C., Vatner S. F. Pentobarbital alters compensatory neural and humoral mechanisms in response to hemorrhage. Am J Physiol. 1982 Nov;243(5):H713–H721. doi: 10.1152/ajpheart.1982.243.5.H713. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES